ALKS - Alkermes plc.


29.28
0.080   0.273%

Share volume: 1,753,106
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.72%

PREVIOUS CLOSE
CHG
CHG%

$29.20
0.08
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Report Date 05-01-2024 07-24-2024 10-24-2024 02-12-2025 05-01-2025 07-29-2025 10-28-2025 02-25-2026
Total revenue 350.372 M 399.131 M 378.143 M 429.986 M 306.510 M 390.657 M 394.185 M 384.547 M
Cost of revenue 58.644 M 61.472 M 63.099 M 62.116 M 49.197 M 49.460 M 51.591 M 46.209 M
Gross profit 291.728 M 337.659 M 315.044 M 367.870 M 257.313 M 341.197 M 342.594 M 338.338 M
    15.74% -6.70% 16.77% -30.05% 32.60% 0.41% -1.24%  
Operating expenses 247.360 M 227.762 M 210.274 M 205.168 M 243.521 M 248.219 M 253.512 M 280.234 M
Selling general and admin 179.749 M 168.113 M 150.382 M 146.994 M 171.704 M 170.849 M 171.773 M 187.196 M
Research and development 67.611 M 59.649 M 59.892 M 58.174 M 71.817 M 77.370 M 81.739 M 93.038 M
Total expenses 248.419 M 227.776 M 210.288 M 205.182 M 243.521 M 248.219 M 253.512 M 280.234 M
    -8.31% -7.68% -2.43% 18.69% 1.93% 2.13% 10.54%  
Operating income 43.309 M 109.883 M 104.756 M 162.688 M 13.792 M 92.978 M 89.082 M 58.104 M
Ebit 43.491 M 111.936 M 105.314 M 163.137 M 15.348 M 93.749 M 88.802 M 60.524 M
Pretax income 46.912 M 116.719 M 110.230 M 169.889 M 25.489 M 104.839 M 100.745 M 60.377 M
    148.80% -5.56% 54.12% -85.00% 311.31% -3.91% -40.07%  
Income tax 7.964 M 22.061 M 17.435 M 24.152 M 3.025 M 17.741 M 17.984 M 11.036 M
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                   
Net income 36.828 M 91.358 M 92.381 M 146.503 M 22.464 M 87.098 M 82.761 M 49.341 M
    148.07% 1.12% 58.59% -84.67% 287.72% -4.98% -40.38%